• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07976887190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/18/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).
 
Event Description
The customer complained that the results for multiple patients tested for elecsys ft4 ii (ft4 ii) and elecsys ft4 iii (ft4 iii) (b)(6) 2018 on a cobas e801 module do not match the clinical picture for these patients.This medwatch will cover ft4 iii.Refer to medwatch with patient identifier (b)(6) for information on the ft4 ii results.The customer provided data for 16 patient samples tested (b)(6) 2018.The customer changed ft4 generations within this time period.The oldest patient samples were tested with ft4 ii and the most recent samples were tested with ft4 iii.The specific date of when patients were tested with ft4 ii versus ft4 iii was not provided.Clinically, the results between ft4 ii and ft4 iii correlate very well.The ft4 ii and ft4 iii results were reported outside of the laboratory where the endocrinologists complained about the results.The patient samples were repeated by another method but the customer declined to provide the actual results.The results by the other method were "normal." there was no allegation that an adverse event occurred.The e801 module serial number was (b)(4).
 
Manufacturer Narrative
The 16 patient samples were submitted for investigation.The customer's high ft4 ii results were reproduced in 15 of the 16 patient samples.Ft4 iii results were comparable to the ft4 ii results and higher than the reference range.Sample id (b)(6) shows values within the reference ranges for all measured parameters.Sample id (b)(6) was investigated further to test for a biotin interference.No biotin was measured in this patient sample and would not be a cause for the elevated results.Samples id (b)(6) were sent to an external laboratory to be measured by the siemens centaur method.The results from the siemens method compared well to the results from the roche method."some" of the patient results seem to be plausible based on the medication they are taking.A reagent specific issue was not identified.The reagent is performing within specification.The investigation was unable to find a definitive root cause.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7521742
MDR Text Key108502203
Report Number1823260-2018-01523
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07976887190
Device Lot Number304694
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 05/02/2018
Initial Date FDA Received05/17/2018
Supplement Dates Manufacturer Received05/02/2018
Supplement Dates FDA Received06/13/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age69 YR
-
-